Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Element Solutions Inc. Common Stock (ESI) vs Inovio Pharmaceuticals Inc (INO) Price & Performance

Element Solutions Inc. Common StockTrade
Inovio Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Element Solutions Inc. Common Stock vs Inovio Pharmaceuticals Inc — how do they compare? Element Solutions Inc. Common Stock trades at $36.56 (market cap $9.06B), while Inovio Pharmaceuticals Inc trades at $1.1 (market cap $119.42M). The key difference: Element Solutions Inc. Common Stock is far larger — about 75.9× Inovio Pharmaceuticals Inc's market cap, and Element Solutions Inc. Common Stock pays a 0.86% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Element Solutions Inc. Common Stock for 0 Days and Inovio Pharmaceuticals Inc for 43 Days on average.

ESIINO
Market Cap
$9.06B$119.42M
Volume
2,417,1802,789,649
Sector
Basic MaterialsHealth
52-Week High
$49.09$2.65
52-Week Low
$22.99$0.66
Typical Hold Time
0 Days43 Days
Enterprise Value
$10.99B$90.75M
Dividend Yield
0.86%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Element Solutions Inc. Common Stock

No Aura AI signal available yet.

Inovio Pharmaceuticals Inc

INO trades at $1.09, down 3.54% on the day, with a bearish technical signal driven by moving averages. The company reported a net loss of $84.95 million in 2025 on minimal revenue of $65,340, with negative profitability metrics, but has beaten EPS estimates in recent quarters. Key near-term catalyst is the FDA's October 30, 2026 PDUFA date for INO-3107.

The investment case hinges on regulatory approval of INO-3107, with a consensus price target of $2.75 implying significant upside. However, extreme financial losses, high cash burn, and dependence on dilutive financing pose substantial risks. Analyst sentiment is cautiously optimistic but reflects high uncertainty.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ESI
100% Buy0% Sell
Avg holding period · 0 Days
INO
95% Buy5% Sell
Avg holding period · 43 Days

About Element Solutions Inc. Common Stock

Element Solutions provides specialty chemical products and technical services. Its solutions support electronics, communications, automotive systems, industrial surface finishing, and offshore energy.

Read more on ESI →

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO →